The Adherence in Brazil is phenomenal, but early treatment with chloroquine and hydroxychloroquine does not reduce mortality from COVID-19

Main Article Content

Kaio Keomma
Alessandro Leite Cavalcanti

Downloads

Download data is not yet available.

Article Details

How to Cite
Keomma, K., & Cavalcanti, A. L. (2021). The Adherence in Brazil is phenomenal, but early treatment with chloroquine and hydroxychloroquine does not reduce mortality from COVID-19. ABCS Health Sciences, 46, e021103. https://doi.org/10.7322/abcshs.2021175.1888
Section
Letters to the Editor

References

1. Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T. Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19. Cochrane Database Syst Rev. 2021;2(2):CD013587. https://doi.org/10.1002/14651858.CD013587.pub2

2. Hill AB. The Environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295-300.

3. Escosteguy CC. Estudos de intervenção. In: Medronho AM, Carvalho DM, Bloch KV, Luiz RR, Werneck GL. Epidemiologia. São Paulo: Atheneu, 2002; p.151-61.

4. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, Steyerberg EW, et al. Systematic review of guidelines on cardiovascular risk assessment which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med. 2010;170(1):27-40. https://doi.org/10.1001/archinternmed.2009.434

5. Calonge N, Petitti DB, DeWitt TG, Dietrich AJ, Gregory KD, Grossman D, et al. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716-26. https://doi.org/10.7326/0003-4819-151-10-200911170-00008